Corporate Tech Investors

Sucampo Pharmaceuticals

Sucampo Pharmaceuticals is a corporate VC investing group that partners with firms that align with the company's business objectives.

Venture Investor Overview

Contact Information

Background Information

Overview

Sucampo Pharmaceuticals, Inc. is focused on the development and commercialization of specialized medicines that meet major unmet medical needs of patients worldwide. Sucampo has two marketed products -- AMITIZA, its lead product, and RESCULA -- and a late-stage pipeline of product candidates in clinical development for orphan disease areas.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/12/2017

Transaction History

Our records indicate that Sucampo Pharmaceuticals invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Peter Greenleaf

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Sucampo Pharmaceuticals has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Subaru | SUEZ Ventures

Share this article

About Our Database of Corporate Tech Investors

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary